Cargando…
Immune-globulin/methylprednisolone/tocilizumab: Lack of response following off-label use in SARS-CoV-2 infection: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298981/ http://dx.doi.org/10.1007/s40278-021-99511-0 |
Ejemplares similares
-
Antibacterials/immune-globulin/methylprednisolone: Lack of efficacy and off label use: case report
Publicado: (2021) -
Methylprednisolone/tocilizumab: Lack of efficacy in off-label use: 7 case reports
Publicado: (2021) -
Methylprednisolone/tocilizumab: Various toxicities, off label use and lack of efficacy: 2 case reports
Publicado: (2022) -
Immune-globulin/methylprednisolone: Lack of efficacy : case report
Publicado: (2022) -
Methylprednisolone/tocilizumab: Intestinal perforation following off-label use: case report
Publicado: (2020)